Fallopian tube neoplasm
Therapeutic area
Reproductive Health
Rare disease
No
- Definition
- A benign or malignant neoplasm affecting the fallopian tube. Representative examples of benign neoplasms include papilloma, adenofibroma, and leiomyoma. Representative examples of malignant neoplasms include carcinoma, carcinosarcoma, and adenosarcoma.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Fallopian tube neoplasm
- Therapeutic area
- Reproductive Health
- fallopian tube neoplasm
- fallopian tube neoplasm
- fallopian tube neoplasm (disease)
- fallopian tube tumor
- fallopian tube tumour
- neoplasm of fallopian tube
- neoplasm of the fallopian tube
- tumor of fallopian tube
- tumor of the fallopian tube
- tumour of fallopian tube
- tumour of the fallopian tube
- Severity
- Unknown
- Oncology
- Reproductive Health
- MONDO ID
- MONDO:0021092
- Parent condition
- MONDO:0002156
Related records
Broader conditions (12)
- Cancer or benign tumor
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Fallopian tube disorder
- Female reproductive system disorder
- Female reproductive system neoplasm
- Human disease
- Neoplasm
- Neoplastic disease or syndrome
- Reproductive system disorder
- Reproductive system neoplasm
Narrower conditions (26)
- Cancer of isthmus of fallopian tube
- Fallopian tube adenocarcinoma
- Fallopian tube adenomatoid tumor
- Fallopian tube adenosarcoma
- Fallopian tube benign neoplasm
- Fallopian tube cancer
- Fallopian tube carcinoma
- Fallopian tube carcinosarcoma
- Fallopian tube clear cell adenocarcinoma
- Fallopian tube cystadenofibroma
- Fallopian tube endometrioid adenocarcinoma
- Fallopian tube endometrioid tumor
- Fallopian tube germ cell tumor
- Fallopian tube gestational choriocarcinoma
- Fallopian tube leiomyoma
- Fallopian tube leiomyosarcoma
- Fallopian tube mucinous adenocarcinoma
- Fallopian tube mucinous tumor
- Fallopian tube papillary adenocarcinoma
- Fallopian tube papilloma
Trials (819)
- "Re-Stimulated" TILs And IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- (PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma
- 18F-CP18 Imaging Studies for Cancer Treatment With Birinapant
- A Beta-only IL-2 ImmunoTherapY Study
- A Biomarker Screening Protocol for Participants With Solid Tumors
- A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.
- A Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
- A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer
- A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer
- A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)
- A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors
- A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies
- A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer
- A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer
- A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients
- A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer.
- A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies
- A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
- A Phase II Combined Modality Protocol of Debulking Surgery With HIPEC Followed by Intraperitoneal Chemotherapy for the Treatment of Recurrent Ovarian, Primary Peritoneal & Fallopian Tube Cancers
Approved drugs (1)
Drugs in development (1)
- Carboplatin Phase 3